ABSTRACT

At nearly every cardiology conference, whether in Europe or in the U.S., new clinical trial data is published. At times, so much information is published that the busy clinical cardiologist does not have time to keep abreast of the latest and preferred therapies. This successive volume examines advances that have taken place since the previous vers

chapter |4 pages

Aortic regurgitation Depression

chapter |1 pages

Conclusion

chapter |6 pages

References

chapter |15 pages

Myocardial ischemia

chapter |7 pages

References

chapter |1 pages

Lipid lowering in coronary prevention

chapter |4 pages

Secondary prevention

chapter |3 pages

References

chapter |2 pages

SERMS

chapter |2 pages

References

chapter |1 pages

Conclusion

chapter |5 pages

References

chapter |9 pages

Diabetes and macrovascular disease

chapter |4 pages

Management of hypertension

chapter |1 pages

Beta-blockers

chapter |8 pages

References

chapter |11 pages

Pathological specimen examinations

chapter |6 pages

References

chapter |3 pages

Thrombin inhibitors

chapter |6 pages

GP IIb/IIIa receptor antagonists

chapter |6 pages

References

chapter 9|1 pages

Myocardial Stunning

chapter |1 pages

Clinical occurrence

chapter |1 pages

Effort angina

chapter |6 pages

Diagnosis

chapter |1 pages

Summary

chapter |4 pages

References

chapter |1 pages

Conclusion

chapter |9 pages

References

chapter |1 pages

Endothelial function

chapter |4 pages

Angina

chapter |2 pages

ACE inhibitors and diastolic

chapter |4 pages

References

chapter |2 pages

ARB myocardial infarction

chapter |3 pages

References

chapter |9 pages

Investigations

chapter |5 pages

References

chapter |3 pages

References

chapter |6 pages

Treatment procedures

chapter |4 pages

Angioplasty

chapter |3 pages

References

chapter 16|12 pages

Syndrome X

chapter |6 pages

References

chapter |1 pages

Single gene disorders

chapter |2 pages

Summary

chapter |1 pages

Family-based linkage studies

chapter |2 pages

Angiotensinogen

chapter |3 pages

Angiotensin II receptor

chapter |4 pages

References

chapter 18|3 pages

Cardiac Rehabilitation

chapter |4 pages

Sexual activity

chapter |6 pages

Patients’ understanding

chapter |4 pages

Current provision

chapter |5 pages

References

chapter |1 pages

Symptomatology

chapter |11 pages

Proarrhythmia risks